Beta Bionics, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Beta Bionics, Inc.
- Regulatory records
- 3
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 3 FDA records to the applicant name Beta Bionics, Inc.. The collection includes 3 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Sep 11, 2026 to Oct 21, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QFG appears in 2 of the 3 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 11 Hughes, Irvine, CA, 92618, US. Recorded on K263422, decision dated Oct 21, 2026.
Device categories in this collection
Alternate Controller Enabled Insulin Infusion Pump; Interoperable Automated Glycemic Controller.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Mint ACE PumpK263422 | Beta Bionics, Inc. | 510(k) clearance | Oct 21, 2026 | FDA |
Mint ACE PumpK260001 | Beta Bionics, Inc. | 510(k) clearance | Sep 11, 2026 | FDA |
| Beta Bionics, Inc. | 510(k) clearance | Sep 11, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 19, 2026.

